ANI Pharmaceuticals ROCE Ratio 2011-2026 | ANIP

Annual ROCE Ratio ANI Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
0.14	10.85	-11.25	-11.92	-8.18	4.16	13.34	7.84	9.2	11.96	7.99	2.19	-82.24	-92.34

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
13.34	-92.34	-9.88

Quarterly ROCE Ratio ANI Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
11.55	5.52	6.51	4.43	12.51	10.35	8.75	2.97	-4.2	-11.71	-13.58	-13.83	-17.8	-8.47	-8.3	-5.01	-2.68	-8.18	-10.55	-8.54	1.61	7.68	15.68	17.36	16.68	17.92	16.35	16.56	16.88	16.21	12.75	12.08	11.14	11.84	14.99	15.6	17.79	20.43	24.22	24.8	17.79	14.31	8.58	4.7	-2.76	-6.25	2.26	0.76	8.61	-16.98	-1.16	-36.1	-69.28	-88.16	-34.45	-34.55	-43.48

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
24.8	-88.16	-0.31

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Xeris Pharmaceuticals XERS	181.87	$ 6.03	-1.55 %	$ 885 M	USA
UroGen Pharma Ltd. URGN	118.38	$ 19.2	-11.52 %	$ 554 M	Israel
uniQure N.V. QURE	-24.32	$ 10.89	-30.36 %	$ 530 M	Niderland
GT Biopharma GTBP	-214.65	$ 0.47	-2.41 %	$ 892 K	USA
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-325.06	-	-13.47 %	$ 169 M	France
AbCellera Biologics ABCL	-16.8	$ 3.74	3.6 %	$ 1.12 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-337.43	-	-18.52 %	$ 27.3 M	Britain
Adverum Biotechnologies ADVM	-196.79	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
ARCA biopharma ABIO	-23.06	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	146.85	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	-32.41	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	167.74	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	-25.04	-	4.01 %	$ 150 M	Canada
CureVac N.V. CVAC	-51.5	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	-29.95	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-180.78	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-28.92	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	99.51	$ 3.36	0.86 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	-39.57	$ 29.16	-3.54 %	$ 1.69 B	USA
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA
Завод ДИОД DIOD	5.84	-	-	-	Russia
Фармсинтез LIFE	-4.03	-	-	-	Russia
Albireo Pharma ALBO	-70.32	-	-0.23 %	$ 916 M	USA
Alector ALEC	-509.01	$ 2.19	-9.77 %	$ 226 M	USA
Entera Bio Ltd. ENTX	-159.29	$ 1.38	-0.72 %	$ 63.3 M	Israel
Allena Pharmaceuticals ALNA	-252.54	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	-119.71	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	-80.08	$ 4.21	-2.32 %	$ 299 M	USA
Teligent, Inc. TLGT	69.22	-	-13.85 %	$ 16.1 M	USA
AlloVir ALVR	-57.76	-	4.14 %	$ 49.1 M	USA
Evogene Ltd. EVGN	-39.87	$ 0.84	-4.24 %	$ 27.9 M	Israel
Viela Bio, Inc. VIE	-40.79	-	-	$ 2.91 B	USA
Ampio Pharmaceuticals AMPE	-75.24	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	-10.92	$ 13.98	1.27 %	$ 5.7 B	Irlanda
AbbVie ABBV	-461.01	$ 233.57	0.64 %	$ 413 B	USA
Blueprint Medicines Corporation BPMC	-60.1	-	-	$ 8.14 B	USA
Applied Molecular Transport AMTI	-209.11	-	-	$ 10.1 M	USA
AIM ImmunoTech AIM	-51.79	$ 0.8	-11.6 %	$ 38.5 M	USA
Apellis Pharmaceuticals APLS	14.97	$ 20.67	-1.38 %	$ 2.61 B	USA